GBIO
Generation Bio Co
NASDAQ: GBIO · HEALTHCARE · BIOTECHNOLOGY
$5.34
+0.00% today
Updated 2026-02-09
Market cap
$35.98M
P/E ratio
—
P/S ratio
2.36x
EPS (TTM)
$-9.37
Dividend yield
—
52W range
$3 – $7
Volume
0.1M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$5.25
-1.69%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-52.68M
- Revenue declining -0.79% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $880000.00 | $5.90M | $19.89M | $15.27M |
| Net income | $-114.67M | $-132.10M | $-126.61M | $-131.67M | $-5.52M |
| EPS | — | — | — | — | $-9.37 |
| Free cash flow | $-97.78M | $-111.25M | $-60.14M | $-90.96M | $-52.68M |
| Profit margin | — | -15,010.91% | -2,144.51% | -661.91% | — |
Peer comparison
Smart narrative
Generation Bio Co trades at $5.34. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $15.27M.
Frequently asked questions
What is Generation Bio Co's stock price?
Generation Bio Co (GBIO) trades at $5.34.
Is Generation Bio Co overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell).
What is the price target of Generation Bio Co (GBIO)?
The analyst target price is $5.25, representing -1.7% downside from the current price of $5.34.
What is Generation Bio Co's revenue?
TTM revenue is $15.27M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.36x
ROE-0.81%
Beta2.01
50D MA$5.52
200D MA$5.11
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—